Press Release
, March 14th, 2018Cognition Therapeutics Co-Founder and CSO Susan Catalano to Present at Sachs Neuroscience Innovation Forum
Press Release
, January 4th, 2018Cognition Therapeutics’ Alzheimer’s Disease Candidate CT1812 Meets Phase 1b/2a Study Objectives: Well Tolerated with Positive Influence on Biomarkers of Synapse Recovery
Press Release
, November 4th, 2017Pharm company plans to start clinic trials of Alzheimer’s treatment by year-end
Pittsburgh Business Times
, September 9th, 2015Cognition Therapeutics Completes Oversubscribed $12 Million Series B Financing
Press Release, September 8th, 2015
Developer of drugs to treat Alzheimer’s raises $12M
Pittsburgh Business Times
, August 5th, 2015